جستجوی استاد راهنمای دانشگاهی

Andrew Wardمشاهده پروفایل

استاد

• Structural Biology
• Virology
• Membrane Proteins
• +۳ مورد دیگر

Andrew B. Ward is a Professor in the Department of Integrative Structural and Computational Biology at The Scripps Research Institute. His research focuses on membrane proteins and viruses, employing integrative structural biology techniques such as x-ray crystallography and electron microscopy. He investigates viral entry mechanisms and antibody-mediated neutralization, with a particular emphasis on HIV, influenza, and other pathogens. Ward’s work aims to design better vaccines by understanding antibody-virus interactions and structural dynamics. Education: Ph.D., The Scripps Research Institute, 2008 B.S., Duke University, 2001 Research Interests: Membrane protein transporters Viral entry mechanisms Structural basis of antibody neutralization Design of broadly neutralizing antibodies Influenza and HIV vaccine development Scientific Awards: Young Investigator in Virology Award (2017) Anne Palmenberg Junior Investigator Award (2014) Ray Thomas Edwards Foundation Fellowship (2013) Advising & Grants: Ward’s lab has contributed to numerous collaborative projects on viral structures and vaccine design. Grants include funding from NIH and the National Science Foundation. His lab’s work frequently involves structural biology and computational modeling to advance immunotherapeutic strategies. Labs/Teams: His laboratory focuses on structural virology and antibody engineering, collaborating with institutes globally to combat infectious diseases.

Yuxing Liمشاهده پروفایل

استاد

• HIV-1 vaccine development
• B cell immunology
• Viral pathogenesis
• +۴ مورد دیگر

Dr. Yuxing Li is a Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine. She leads an integrated research program focused on B cell responses to viral infections, particularly HIV-1 and Ebola virus, with an emphasis on vaccine development, immunotherapeutics, and structural biology of envelope glycoproteins. Education: B.S. in Genetics (Sichuan University, China), M.S. in Microbiology (Sichuan Industrial Institute of Antibiotics), Ph.D. in Genetics (Iowa State University). Her research explores mechanisms of protective immunity through structural and immunologic analysis of viral envelope proteins, aiming to develop broadly effective vaccines. Recent work includes designing multi-specific antibodies for HIV and identifying pan-filovirus therapeutic targets. She has authored key publications in Nature Communications , Cell , and Science , focusing on HIV-1 vaccine design and Ebolavirus immunology. Her lab’s article trends highlight structural biology, viral entry inhibition, and cross-protective antibody development. Scientific Awards: Merit Award (NIAID/NIH), CFAR Young Investigator Award, Staff Exceptional Performance Award (VRC), NIH Fellow Award for Research Excellence. Dr. Li has secured multiple NIH grants, including R01 and P01 awards, and leads projects on filovirus B cell responses and high-resolution HIV Env immunogen design. She is affiliated with the Institute for Bioscience and Biotechnology Research (IBBR) and collaborates with scientists in structural biology and virology.

Marceline Côtéمشاهده پروفایل

استاد

• Host-pathogen interactions
• Emerging viruses
• Antiviral therapeutics
• +۳ مورد دیگر

Dr. Marceline Côté is a Professor in the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa's Faculty of Medicine. She serves as Director of the Centre for Infection, Immunity and Inflammation (CI3), where she leads research on host-pathogen interactions during emerging viral infections. BSc from Université de Sherbrooke (2004) PhD from McGill University (2009) Postdoctoral Fellowship at Brigham and Women's Hospital & Harvard Medical School Her research focuses on identifying host proteins critical for viral infection by filoviruses (Ebola, Marburg), arenaviruses (Lassa fever), and coronaviruses (SARS-CoV, SARS-CoV-2, MERS). Using virological, chemical biology, and genetic approaches, she investigates viral entry pathways and develops antiviral therapeutics targeting host factors. Recent publications highlight her work on SARS-CoV-2 entry mechanisms, filovirus trafficking, and diacylglycerol kinase inhibition as an antiviral strategy. Her lab explores how pathogens exploit endosomal phosphoinositides and intracellular vesicular trafficking systems.

Julia Rebecca Portمشاهده پروفایل

استاد پژوهش

• Viral Transmission
• Immunopathology
• Aerosol Dynamics
• +۴ مورد دیگر

Dr. Julia Rebecca Port leads the Laboratory of Transmission Immunology at the Helmholtz Centre for Infection Research (Braunschweig, Germany), where she investigates viral transmission mechanisms and host immunity. She holds a B.Sc. in Molecular Medicine (Eberhard Karls University of Tübingen) and M.Sc. in Biomedical Sciences (University of Antwerp). Her PhD research at Leibniz Institute for Virology focused on viral pathogenesis under Prof. César Muñoz-Fontela. Her research examines aerosol transmission dynamics, mucosal immunity, and zoonotic spillover, with emphasis on: Bat immunology and microbiome interactions Variant-specific SARS-CoV-2 transmission fitness Mpox virus shedding patterns Immunopathology of emerging viruses Her publication trends reveal deep expertise in experimental virology, using hamster, bat, and primate models to study transmission bottlenecks, immune evasion, and intervention strategies. Awards include: NIH Director's Award (multiple) NIH Merit Award (multiple) She secured the Helmholtz Young Investigator Grant (2024) to establish her independent group. Current work focuses on developing transmission-blocking interventions and characterizing bat antiviral immunity. Leads collaborations with NIH, Bernhard Nocht Institute, and international consortia on pandemic preparedness.

Lay Teng Angمشاهده پروفایل

استادیار

• Stem Cell Biology
• Developmental Biology
• Regenerative Medicine
• +۴ مورد دیگر

Lay Teng Ang is an Assistant Professor of Urology at Stanford University, with concurrent appointments at the Bio-X , Cardiovascular Institute , and Institute for Stem Cell Biology & Regenerative Medicine . His research focuses on stem cell differentiation mechanisms and their applications in vascular biology, hematopoiesis, and neuroinflammation. Doctoral training at University of Cambridge and A*STAR Professional background includes Genome Institute of Singapore and Stanford Institute for Stem Cell Biology Research interests span pluripotent stem cell lineage specification , endothelial cell heterogeneity , and therapeutic targeting of EPAS1/ACKR1 pathways . His work has produced protocols for generating highly pure hematopoietic progenitors and organ-specific endothelial cells . Key publications include: 2025: Venous dysfunction in vascular dementia (Nature Communications) 2024: Hematopoietic stem cell lineage tracing (Developmental Cell) 2023: Germ cell specification mechanisms (Nature Communications) 2022: Meningococcal disease susceptibility via CFHR3 variation (AJHG) Awards include Catalyst to Independence and Siebel Investigatorship grants, with affiliations spanning the American Heart Association and Stanford Maternal & Child Health Research Institute .

• Virology
• Virus-Host Interactions
• Viral Pathogenesis
• +۵ مورد دیگر

Alexandra Schaefer, PhD, is an Associate Professor in the Department of Epidemiology at the University of North Carolina’s Gillings School of Global Public Health. Her research focuses on virus-host interactions, viral pathogenesis, and the role of host genetics in infections caused by coronaviruses (e.g., SARS-CoV, MERS-CoV, SARS-CoV-2) and filoviruses (e.g., Ebola and Marburg). She investigates quantitative trait loci, genes, and alleles influencing disease severity across species using mouse and human models. A key goal is identifying common genetic susceptibility factors for emerging viral diseases and developing population-based models to study coronavirus evolution and antiviral therapies. Education PhD in Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 2003 MS in Biology, Johannes Gutenberg Universität Mainz, 1999 Research Interests Dr. Schaefer’s work bridges virology, genetics, and public health. She explores how host genetics modulate immune responses to emerging viruses, with a focus on identifying genetic markers predictive of disease outcomes. Her lab develops outbred mouse models to simulate human viral infections and evaluates antiviral drugs and vaccines in real-time pandemic scenarios. Recent studies include genetic determinants of Ebola virus susceptibility and SARS-CoV-2 pathogenesis. Awards Named to Clarivate’s Highly Cited Researchers List in 2022, 2023, and 2024, recognizing impactful contributions to virology and public health research. Labs and Affiliations Based in the Michael Hooker Research Center, her work aligns with the Gillings School’s mission to address global public health challenges through interdisciplinary research. She contributes to initiatives like the Gillings Innovation Labs and the North Carolina Institute for Public Health.

• Pediatric Infectious Diseases
• Vaccinology
• Immunocompromised Hosts
• +۳ مورد دیگر

Inci Yildirim is an Associate Professor of Pediatrics (Infectious Disease) and Public Health (Epidemiology of Microbial Diseases) at Yale University. She holds dual appointments in the Yale School of Medicine and Yale School of Public Health. Her roles include Section Chief of Pediatric Infectious Diseases and Global Health, Medical Director of Transplant Infectious Diseases at Yale New Haven Children’s Hospital, and Director of the Pediatric Vaccine Trials Program. Dr. Yildirim’s research focuses on vaccine-induced immune responses in immunocompromised children, particularly those with organ transplants or sickle cell disease. Education: MD and MSc from Hacettepe University, Turkey PhD in Epidemiology from Boston University Pediatric Infectious Diseases Residency at Yale School of Medicine Research Interests: Dr. Yildirim investigates vaccine efficacy in high-risk pediatric populations, including transplant recipients and patients with sickle cell disease. Her work emphasizes understanding immune responses to vaccines such as those for SARS-CoV-2, RSV, and pneumococcal infections. She leads studies on global health equity, including environmental surveillance for infectious diseases in resource-limited settings. Key Contributions: Her research has advanced understanding of long COVID pathophysiology, mRNA vaccine safety, and pneumococcal vaccine effectiveness in vulnerable groups. She has pioneered the Yale Pediatric Vaccine Trials Program, contributing to clinical trials for vaccines targeting emerging pathogens. Labs & Teams: Her lab, the Yildirim Laboratory, collaborates with global networks to address pediatric infectious disease challenges. She leads the Network of Vaccine Initiatives and is affiliated with the Yale Institute for Global Health and Center for Infection and Immunity.

• Vaccinology
• Immunology
• Infectious Diseases
• +۴ مورد دیگر

Professor Teresa Lambe serves as Calleva Head of Vaccine Immunology and Professor of Vaccinology & Immunology at the University of Oxford, based in the Department of Paediatrics within the Medical Sciences Division. She is a Principal Investigator at the Oxford Vaccine Group and leads The Lambe Group, focusing on vaccine development against emerging pathogens to prevent epidemics through rational immunological design. Her research centers on delineating protective immune responses post-infection and vaccination, with emphasis on long-lived immunity and outbreak pathogen countermeasures. Key interests include vaccine development for Ebola, Marburg, Crimean-Congo hemorrhagic fever, and coronaviruses , utilizing viral vector platforms like ChAdOx1 to create rapid-response vaccines. Her work bridges preclinical immunology and clinical translation for pandemic preparedness. Recent 2025 publications demonstrate her group's leadership in advancing vaccines across multiple threat categories, from COVID-19 booster strategies to bivalent filovirus vaccines and One Health approaches for Nipah virus. This portfolio reflects a consistent focus on high-impact translational vaccinology targeting WHO priority pathogens. Scientific recognition includes: honorary OBE for services to Sciences and Public Health (2021 Queen's Birthday Honours) Presidential Distinguished Service Award for the Irish Abroad (2022) As lead for the Oxford/AstraZeneca COVID-19 vaccine development (co-designer, preclinical lead), Lambe's team has driven multiple candidates into WHO-backed outbreak responses, including ring vaccination trials for Ebola in Uganda and Marburg virus countermeasures. Her group secures significant translational research funding for clinical-stage vaccine development against tier-1 pandemic threats. The Lambe Group operates within the Oxford Vaccine Group infrastructure, collaborating with the Jenner Institute and WHO emergency programs to advance vaccine candidates from bench to outbreak deployment, with current clinical trials spanning four viral hemorrhagic fever platforms.

Kartik Chandranمشاهده پروفایل

استاد

• Emerging viruses
• Ebola and Marburg viruses
• Hantaviruses
• +۴ مورد دیگر

Kartik Chandran is a Professor and the Gertrude and David Feinson Chair in Medicine in the Department of Microbiology & Immunology at Albert Einstein College of Medicine. His research focuses on understanding the molecular mechanisms of viral entry and pathogenesis, particularly for emerging viruses such as Ebola, Marburg, and hantaviruses. He leads the Chandran Lab, which investigates viral-host interactions, antiviral therapies, and vaccine development. Research Interests: Dr. Chandran’s work centers on filoviruses and bunyaviruses, with a focus on viral fusion glycoproteins, host receptors (e.g., NPC1), and the development of antibodies and small molecules to combat infections. His team has identified critical host factors enabling viral entry and explored genetic determinants of viral susceptibility. Recent studies include antibody therapies against Crimean-Congo hemorrhagic fever, SARS-CoV-2 antigen design, and pan-filovirus protection strategies. The lab’s translational efforts aim to translate basic discoveries into clinical antivirals and vaccines. Grants & Collaborations: Collaborations span institutions globally, including work on monkeypox immune responses and hantavirus vaccines. The lab actively recruits postdoctoral fellows for projects in viral pathogenesis and antiviral development. Labs/Teams: The Chandran Lab is part of the Einstein’s Center for RNA Science and Therapeutics, emphasizing interdisciplinary research on viral RNA and host interactions.

Logan Banadygaمشاهده پروفایل

استاد مدعو

• Filovirus Pathogenesis
• Molecular Virology
• Medical Countermeasures
• +۵ مورد دیگر

Logan Banadyga is an Adjunct Professor at the Max Rady College of Medicine , University of Manitoba, and a Research Scientist at the National Microbiology Laboratory, Public Health Agency of Canada. Appointed head of the Molecular Virology and Countermeasure Development Section (Special Pathogens Program) in 2021 Active in graduate student supervision (accepting Master's and PhD students) Education Doctor of Philosophy in Virology, University of Alberta (2011) Bachelor of Science with Honours in Immunology and Infection, University of Alberta (2005) Research Interests focus on filoviruses (Ebola, Marburg, Sudan) with emphasis on: Molecular mechanisms of viral pathogenesis Development of vaccines, antivirals, and diagnostics Characterization of animal models for disease understanding and countermeasure evaluation Integration with public health preparedness initiatives Scientific Awards reflect his contributions: National Institutes of Health Intramural Research Training Award Alberta Heritage Foundation for Medical Research Studentship NSERC Alexander Graham Bell Canada Graduate Scholarship NSERC Post-graduate Scholarship Currently based at the Basic Medical Sciences Building (745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9) with affiliations spanning academic research, federal public health infrastructure, and graduate training programs.

• Virology
• Immunology
• Microbiology
• +۴ مورد دیگر

Judith Olejnik is a Senior Research Scientist in the Muhlberger Lab at Boston University, affiliated with Boston University CAMED and BUMC Cores. Her work focuses on virology, immunology, and microbiology, particularly investigating viral pathogenesis, host responses, and antiviral strategies against pathogens like Ebola, SARS-CoV-2, and RSV. Her research emphasizes understanding mechanisms of viral infection, immune evasion, and age-related susceptibilities. Key interests include STAT3 signaling in respiratory infections, ACE2 regulation during SARS-CoV-2 infection, and the development of robust viral inactivation protocols for genomic analysis. She has contributed to studies on filovirus replication, host-pathogen interactions, and the role of minor introns in viral infections. Notably, she received the 2025 Corwin Award for her contributions. Her work integrates cutting-edge genomics (e.g., ViBE-Seq for filovirus RNA analysis) and interdisciplinary approaches to tackle emerging pathogens. She collaborates with the Muhlberger Lab to advance infectious disease research and translational antiviral strategies.

Ariful Islamمشاهده پروفایل

مدرس

• Epidemiology
• Evolutionary Ecology
• Zoonotic Diseases
• +۷ مورد دیگر

Dr Ariful Islam is a Lecturer at the Gulbali Institute, Charles Sturt University , specializing in epidemiology and evolutionary ecology of emerging infectious diseases . With over 15 years of experience, his research focuses on zoonotic viruses like henipaviruses, filoviruses, coronaviruses, and avian influenza, employing a One Health framework. Masters in Public Health (MPH), American International University - Bangladesh Doctor of Philosophy (PhD), Deakin University Master of Science (MS) in Pharmacology, Chattogram Veterinary and Animal Sciences University Doctor of Veterinary Medicine (DVM), Chattogram Veterinary and Animal Sciences University His research integrates viral genetics, statistical modeling, and behavioral ecology to prevent disease transmission. Key areas include zoonotic spillover dynamics , avian influenza epidemiology , and biosecurity practices in poultry systems. Recent publications highlight his work on Nipah virus spillover , avian influenza in Bangladesh , and antimicrobial resistance in livestock. He collaborates across institutions in Australia and Bangladesh, contributing to global biosecurity and pandemic preparedness.

Kirsi Aaltonenمشاهده پروفایل

پژوهشگر

• Veterinary Science
• Virology
• Zoonotic Diseases
• +۵ مورد دیگر

Kirsi Aaltonen is a Postdoctoral Researcher at the University of Helsinki's Faculty of Medicine, Department of Virology, and a member of the Helsinki One Health Research organization. Her work focuses on veterinary virology with emphasis on zoonotic diseases and the One Health approach connecting human, animal, and environmental health. Dr. Aaltonen's research spans multiple critical areas of viral infections with particular emphasis on emerging pathogens. Her work includes studies on SARS-CoV-2 transmission in mink populations, avian influenza, parapoxviruses, and various other zoonotic viruses. She has made significant contributions to understanding viral transmission dynamics between animals and humans, particularly in agricultural and wildlife settings. Her recent publications (2023-2025) reveal strong research activity in viral transmission mechanisms, particularly focusing on SARS-CoV-2 in mink populations, avian influenza in wildlife and fur farms, and diagnostic methods for viral infections. The articles demonstrate interdisciplinary work combining virology, epidemiology, veterinary pathology, and molecular biology approaches to address emerging infectious disease threats. Dr. Aaltonen serves as a supervisor for the Doctoral Programme in Clinical Veterinary Medicine, contributing to the training of future veterinary researchers. She is actively involved in multiple research projects funded by various organizations including private foundations, the World Organisation for Animal Health (WOAH), and the Research Council of Finland.

• Virology
• Immunology
• Microbiology
• +۴ مورد دیگر

John H. Connor is a Professor and Vice Chair in the Department of Virology, Immunology & Microbiology at Boston University's Chobanian & Avedisian School of Medicine. He holds additional roles in the National Emerging Infectious Disease Lab, Genome Science Institute, and Bioinformatics Graduate Program. His research focuses on virus-host interactions, particularly how viruses hijack cellular machinery and evade immune responses. He has contributed to studies on Ebola, SARS-CoV-2, and other pathogens, with a focus on antiviral drug development and diagnostic tools. Education: B.A. from Swarthmore College, Ph.D. in Pharmacology from Duke University. Research interests include viral replication mechanisms, host immune responses, and translational research for emerging infectious diseases. His lab investigates protein synthesis co-option by viruses, innate immune evasion tactics, and viral genetic diversity in transmission networks. Recent work emphasizes SARS-CoV-2 pathogenesis, including thrombotic complications and Omicron variant behavior. He leads NIH-funded projects on antiviral inhibitors, vaccine development, and diagnostics for viral hemorrhagic fevers. Affiliations include Boston University's Center for Antiviral Research and Development (CAMED), and he collaborates with institutions like the University of Texas Medical Branch and RedBud Labs on vaccine efficacy and diagnostics initiatives.

• Virology
• Immunology
• Microbiology
• +۳ مورد دیگر

Robert Davey is a Professor of Virology, Immunology & Microbiology and Interim Director of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University's Chobanian & Avedisian School of Medicine. He holds a PhD from the University of Adelaide and has extensive postdoctoral training at the Howard Hughes Medical Institute and Harvard Medical School. His research focuses on hemorrhagic fever viruses, including Ebola, Marburg, Lassa, and Nipah, with an emphasis on developing small molecule-based treatments and understanding viral entry mechanisms. Dr. Davey's work utilizes BSL4 facilities at the NEIDL to study high-risk pathogens. His lab employs high-throughput screening and systems biology approaches to identify host proteins critical for viral infection, aiming to disrupt these interactions for therapeutic development. He has held leadership roles, including Interim Chair at the Texas Biomedical Research Institute and Director of ABSL4 facilities. His research spans antiviral drug discovery, host-pathogen interactions, and collaborative studies with institutions like the Texas Biomedical Research Institute and Scripps Research. Dr. Davey's team has contributed to high-impact publications in Science , PNAS , and PLoS Pathogens , focusing on viral entry inhibitors and host factor dependencies. Current and past grants include NIH-funded projects on filovirus inhibitors, SARS-CoV-2 treatments, and antiviral lead identification. His interdisciplinary approach integrates molecular biology, cell biology, and pharmacology to combat emerging viral threats.